|
THOC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.435200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.600000E-02 |
| Normal-vs-Stage2 |
4.771700E-02 |
| Normal-vs-Stage3 |
5.803900E-03 |
| Normal-vs-Stage4 |
6.542200E-03 |
| Stage1-vs-Stage2 |
3.044600E-01 |
| Stage1-vs-Stage3 |
1.092240E-01 |
| Stage1-vs-Stage4 |
6.401500E-02 |
| Stage2-vs-Stage3 |
8.809400E-01 |
| Stage2-vs-Stage4 |
5.077000E-01 |
| Stage3-vs-Stage4 |
5.413400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.356500E-03 |
| Normal-vs-AfricanAmerican |
9.267600E-01 |
| Normal-vs-Asian |
1.081110E-03 |
| Caucasian-vs-AfricanAmerican |
1.712370E-01 |
| Caucasian-vs-Asian |
1.680400E-01 |
| AfricanAmerican-vs-Asian |
1.731670E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.095920E-02 |
| Normal-vs-Female |
4.756500E-03 |
| Male-vs-Female |
7.852600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.894500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.146100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.881260E-03 |
| Normal-vs-Age(81-100Yrs) |
2.124400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.838600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.576100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.892000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.354200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.410200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.055200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.057000E-01 |
| Classical-VS-Follicular |
9.768200E-01 |
| Classical-VS-Other |
5.035600E-01 |
| Classical-VS-Normal |
3.699700E-03 |
| Tall-VS-Follicular |
5.876400E-01 |
| Tall-VS-Other |
7.577800E-01 |
| Tall-VS-Normal |
2.846000E-02 |
| Follicular-VS-Other |
5.644000E-01 |
| Follicular-VS-Normal |
4.123700E-02 |
| Other-VS-Normal |
2.174000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.400400E-02 |
| Normal-vs-N1 |
2.686100E-02 |
| N0-vs-N1 |
4.380600E-01 |
|
|
